MAP2K5 and small cell lung carcinoma: For example, metabolism‐associated genes of small cell lung cancer (SCLC) cells altered after mitogen‐activated protein kinase (MAPK) kinase module MEK5/ERK5 was blocked, accompanied by dysfunctions of several lipid metabolism pathways like the mevalonate pathway for cholesterol synthesis.1